A Pilot Randomised Trial Investigating the Effects of Including Efficacy Messaging on Tobacco Warning Labels
Lillian Brinken1, Stuart G Ferguson1, Marie-Jeanne Buscot1
1University of Tasmania, Hobart, Australia.
Summary
Adding efficacy messages to tobacco warning labels did not increase quitting intentions in smokers. However, self-efficacy and risk perception remain key predictors of quitting intentions, suggesting future research is needed.
Area of Science:
- Public Health
- Behavioral Science
- Health Communication
Background:
- Smokers may exhibit defensive reactions to health risk communication, diminishing the impact of warning labels.
- Existing tobacco warning labels primarily focus on risk, often neglecting self-efficacy, a crucial factor in behavior change.
- Theoretical models suggest that risk perception and self-efficacy jointly mitigate defensive responses and influence target behaviors.
Purpose of the Study:
- To evaluate the effectiveness of integrating efficacy content with Australian tobacco warning labels.
- To determine if combined efficacy and risk messages enhance smokers' intentions to quit.
Main Methods:
- A 3-week randomized controlled trial involving 83 smokers.
- Participants were assigned to receive either standard health warning labels (HWLs) with enhanced efficacy messages or unmodified standard HWLs.
- Daily self-reported cognitions and smoking behavior were collected via smartphone, with analysis using multilevel structural equation modeling.
Main Results:
- Exposure to efficacy messages did not significantly impact self-efficacy, risk perception, or quitting intentions.
- A positive association was observed between self-efficacy, risk perception, and quitting intentions at the within-person level.
Conclusions:
- While self-efficacy and risk perception predict quitting intentions, supplementing standard HWLs with efficacy content did not enhance these outcomes.
- Further investigation is required to understand the reasons for the lack of effect, such as message characteristics or avoidance behaviors.
- Future research should explore the optimal contexts and populations for efficacy-enhancing messages and their temporal influence on cessation.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
162
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
162
Hazard Ratio
216
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
216
Framing Effects
7.5K
Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in...
7.5K
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
The Placebo Effect
6.3K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.3K
Blind Procedures
10.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K


